Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Pharmaceutical Sciences · China · 2025-03-17

Processing Time
51 days
Decision Date
2025-03-17
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop novel and advanced drug delivery systems for new drug products to support animal studies and clinical trials across a wide scope of treatment indications. His work specifically focuses on improving the bioavailability, precision, and controlled release of medications to address the global burden of cardiovascular diseases (CVDs).

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cardiovascular diseases, a leading cause of global death, by improving drug delivery precision.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a documented history of published research and citations in pharmaceutical sciences.

3 On Balance, Beneficial to Waive Job Offer Requirement Met

The petitioner's innovations in drug delivery systems provide significant public health benefits that outweigh the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pharmaceutical sciences and a strong record of 9 peer-reviewed journal articles and 2 book chapters. His research has garnered 130 citations, demonstrating his influence in the field and his ability to advance drug delivery systems that address critical health issues like cardiovascular disease. The case satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 180 days 2025-08-20
The petitioner proposes to continue research on biomolecular delivery vehicles to create novel drug delivery systems. This work focuses on enhancing drug targeting, controlled release, and bioavailability for the treatment of cancer and chronic diseases.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Postdoctoral Researcher

Chemicals · India

WeGreened EB-2 (NIW) approved
Massachusetts 156 days 2022-10-04
The petitioner proposes to continue research on developing state-of-the-art drug delivery approaches that cross biological interfaces. This work focuses on enabling the facile treatment of a wide range of disorders, including neurological disorders, metastatic cancer, and COVID-19, through protein-based therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 51 days
Criteria Met 3 / 3
Evidence Types 2

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist